Evox Therapeutics competitorsClear all

Biocept's top competitors include Exosome Diagnostics and Codiak Biosciences.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Biocept
Biocept
Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
Exosome Diagnostics
Exosome Diagnostics
Exosome Diagnostics develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives.
Codiak Biosciences
Codiak Biosciences
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
Founding Date
Founding Date
1993
Founding Date
2008
Founding Date
2015
Type
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
Waltham, US HQ
Martinsried, DE
Athens, US
Huntsville, US
Mobile, US
Montgomery, US
Opelika, US
see more
Locations
Cambridge, US HQ
Employees
Employees
878% decrease
Employees
842% decrease
Employees
101
Valuation ($)
Valuation ($)
52.4 m
Valuation ($)
N/A
Valuation ($)
308 m
Twitter followers
Twitter followers
2.4 k
Twitter followers
1.4 k
Twitter followers
180
Number of tweets (last 30 days)
Number of tweets (last 30 days)
22
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
2.1
Average likes per tweet (last 30 days)
2
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
90.91%
Percentage of tweets with engagement (last 30 days)
60%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
196942
Alexa Website Rank
266272
Alexa Website Rank
N/A
Employee Rating
Employee Rating
3.9
Employee Rating
1.9
Employee Rating
4.2

Financial

Revenue (est.)
Revenue (est.)
$27.5m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$2.9m (FY, 2020)
Net income
Net income
($17.8m) (FY, 2020)
Net income
N/A
Net income
($91.7m) (FY, 2020)

Funding

Total funding raised
Total funding raised
$ 15.9m
Total funding raised
$ 112.1m
Total funding raised
$ 168.5m
For sources of this data, please see the company profile

View company profiles

Exosome Diagnostics
HQ
Waltham, US
Employees
84↓ 2% decrease

Exosome Diagnostics develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives.

View company
Codiak Biosciences
HQ
Cambridge, US
Employees
101

Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.

View company